Close
Close
Treatment Database
arimoclomol
Trade Name not avaiable
Orphan Indication Inclusion body myositis
USA Market Approval
USA Designation Date 02-11-2017
Sponsor Orphazyme ApS
Ole Maaloes Vej 3, 2200 Copenhagen

More about Inclusion Body Myositis
Free Newsletter
Videos